Drug Pricing Stewardship from Mark Cuban's Cost Plus Generic Drug Program.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1279, doi. 10.1007/s40273-024-01426-3
- By:
- Publication type:
- Article
Works matching IS 11707690 AND DT 2024 AND VI 42 AND IP 11
Results: 10
1
2
Treatment Effect Waning in Immuno-oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence with Proposals to Guide Modelling.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1181, doi. 10.1007/s40273-024-01423-6
- By:
- Publication type:
- Article
3
Delaying Oral Anticoagulants: A False Economy?
- Published in:
- 2024
- By:
- Publication type:
- Letter
4
Using Cure Modelling for Cost Effectiveness in the NICE Technology Appraisal of Polatuzumab Vedotin in Combination for Untreated Diffuse Large B Cell Lymphoma: An External Assessment Group Perspective.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1177, doi. 10.1007/s40273-024-01421-8
- By:
- Publication type:
- Article
5
Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1209, doi. 10.1007/s40273-024-01410-x
- By:
- Publication type:
- Article
6
Delay and Pay? Healthcare Costs Associated with Late Oral Anti-coagulant Prescribing in People with Atrial Fibrillation.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1241, doi. 10.1007/s40273-024-01419-2
- By:
- Publication type:
- Article
7
Empirical Testing of Alternative Search Methods to Retrieve Utility Values for Health Economic Modelling.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1255, doi. 10.1007/s40273-024-01414-7
- By:
- Publication type:
- Article
8
Considerations Around the Inclusion of Children and Young People's Time in Economic Evaluation: Findings from an International Delphi Study.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1267, doi. 10.1007/s40273-024-01411-w
- By:
- Publication type:
- Article
9
Improving Transparency of Decision Models Through the Application of Decision Analytic Models with Omitted Objects Displayed (DAMWOOD).
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1197, doi. 10.1007/s40273-024-01401-y
- By:
- Publication type:
- Article
10
Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 11, p. 1287, doi. 10.1007/s40273-024-01420-9
- By:
- Publication type:
- Article